Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Eskens FA, van Erpecum KJ, de Jong KP, van Delden OM, Klumpen HJ, Verhoef C, Jansen PL, van den Bosch MA, Méndez Romero A, Verheij J, Bloemena E, de Man RA. Eskens FA, et al. Among authors: de man ra, de jong kp. Neth J Med. 2014 Jul;72(6):299-304. Neth J Med. 2014. PMID: 25319854 Free article. Review.
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
Ayez N, van der Stok EP, de Wilt H, Radema SA, van Hillegersberg R, Roumen RM, Vreugdenhil G, Tanis PJ, Punt CJ, Dejong CH, Jansen RL, Verheul HM, de Jong KP, Hospers GA, Klaase JM, Legdeur MC, van Meerten E, Eskens FA, van der Meer N, van der Holt B, Verhoef C, Grünhagen DJ. Ayez N, et al. Among authors: de wilt h, de jong kp. BMC Cancer. 2015 Mar 26;15:180. doi: 10.1186/s12885-015-1199-8. BMC Cancer. 2015. PMID: 25884448 Free PMC article. Clinical Trial.
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
Huiskens J, van Gulik TM, van Lienden KP, Engelbrecht MR, Meijer GA, van Grieken NC, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, de Jong KP, Dejong KH, Kazemier G, Ruers TM, de Wilt JH, van Tinteren H, Punt CJ. Huiskens J, et al. Among authors: de jong kp, de wilt jh. BMC Cancer. 2015 May 6;15:365. doi: 10.1186/s12885-015-1323-9. BMC Cancer. 2015. PMID: 25943574 Free PMC article. Clinical Trial.
Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF, Tielen R, van Hillegersberg R, van Coevorden F, de Jong KP, Nagtegaal ID, Verhoef C, de Wilt JH; Dutch Liver Surgery Working Group. Seesing MF, et al. Among authors: de jong kp, de wilt jh. Eur J Surg Oncol. 2016 Sep;42(9):1407-13. doi: 10.1016/j.ejso.2016.02.257. Epub 2016 Mar 10. Eur J Surg Oncol. 2016. PMID: 27038995
Liver Resection for Hepatic Metastases from Soft Tissue Sarcoma: A Nationwide Study.
Grimme FAB, Seesing MFJ, van Hillegersberg R, van Coevorden F, de Jong KP, Nagtegaal ID, Verhoef C, de Wilt JHW; On behalf of the Dutch Liver Surgery Working Group. Grimme FAB, et al. Among authors: de wilt jhw, de jong kp. Dig Surg. 2019;36(6):479-486. doi: 10.1159/000493389. Epub 2018 Sep 25. Dig Surg. 2019. PMID: 30253419 Free PMC article.
Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
Huiskens J, Bolhuis K, Engelbrecht MR, De Jong KP, Kazemier G, Liem MS, Verhoef C, de Wilt JH, Punt CJ, van Gulik TM; Dutch Colorectal Cancer Group. Huiskens J, et al. Among authors: de jong kp, de wilt jh. J Am Coll Surg. 2019 Dec;229(6):523-532.e2. doi: 10.1016/j.jamcollsurg.2019.08.1445. Epub 2019 Sep 11. J Am Coll Surg. 2019. PMID: 31520695 Clinical Trial.
B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases.
Hof J, Visser L, Höppener DJ, Nierop PMH, Terpstra MM, Gouw ASH, Grünhagen DJ, Verhoef C, Sijmons RH, de Jong KP, Kok K. Hof J, et al. Among authors: de jong kp. Front Oncol. 2020 Mar 5;10:249. doi: 10.3389/fonc.2020.00249. eCollection 2020. Front Oncol. 2020. PMID: 32195184 Free PMC article.
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016.
Reinders MTM, van Meer S, Burgmans MC, de Jong KP, Klümpen HJ, de Man RA, Ramsoekh DS, Sprengers D, Tjwa ETTL, de Vos-Geelen J, van Erpecum KJ, van der Geest LGM; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Reinders MTM, et al. Among authors: de man ra, de jong kp, de vos geelen j. Eur J Cancer. 2020 Sep;137:214-223. doi: 10.1016/j.ejca.2020.07.008. Epub 2020 Aug 13. Eur J Cancer. 2020. PMID: 32799035
Study Protocol PROMETHEUS: Prospective Multicenter Study to Evaluate the Correlation Between Safety Margin and Local Recurrence After Thermal Ablation Using Image Co-registration in Patients with Hepatocellular Carcinoma.
Oosterveer TTM, van Erp GCM, Hendriks P, Broersen A, Overduin CG, van Rijswijk CSP, van Erkel AR, van der Meer RW, Tushuizen ME, Moelker A, Meijerink MR, van Delden OM, de Jong KP, van der Leij C, Smits MLJ, Urlings TAJ, Braak JPBM, Meershoek-Klein Kranenbarg E, van Duijn-de Vreugd B, Zeijdner E, Goeman JJ, Fütterer JJ, Coenraad MJ, Dijkstra J, Burgmans MC. Oosterveer TTM, et al. Among authors: de jong kp. Cardiovasc Intervent Radiol. 2022 May;45(5):606-612. doi: 10.1007/s00270-022-03075-5. Epub 2022 Mar 1. Cardiovasc Intervent Radiol. 2022. PMID: 35233662 Free PMC article.
296 results